胃腸がんにおけるARID1Aの分子相互作用
PubMedで要約を見る
まとめ
この要約は機械生成です。ARID1A遺伝子はクロマチンの改造に不可欠であり,胃腸がんの腫瘍抑制剤または腫瘍遺伝子の役割を果たします. その変化は 予後と治療に影響し 精密腫瘍学の可能性を強調しています
科学分野
- 腫瘍学
- 分子生物学
- 遺伝学
背景
- ARID1Aは,SWI/SNF染色体改造複合体のサブユニットであり,腫瘍抑制剤または腫瘍遺伝子として文脈に依存する役割を持っています.
- ARID1Aの変異は,食道,胃,肝細胞,臓,大腸がんを含む胃腸がんで頻繁に見られます.
- ARID1Aの減少は,予後が悪いこと,腫瘍の攻撃性の増加,および様々ながんにおける治療抵抗性に関連しています.
研究 の 目的
- 胃腸がんの発症,進行,治療反応におけるARID1Aの多面的な役割を調査する.
- 異なる胃腸がんにおけるARID1A変異の予後および治療的影響を分析する.
- 精密腫瘍学戦略に ARID1A ステータスを統合する可能性を検討する.
主な方法
- 胃腸がんにおけるARID1A変異シグネチャーと発現パターンのバイオ情報分析
- 腫瘍性経路におけるARID1Aの機能に関する遺伝子および分子研究のレビュー (例えば,PI3K/AKT,YAP/TAZ).
- miRNAによるARID1Aの調節と,腫瘍の進行および治療抵抗に対するその影響の検討.
主要な成果
- ARID1Aの減少は,免疫チェックポイントの発現とともに,胃がんにおける侵入性の向上と生存率の低下と相関しています.
- 大腸がんでは,ARID1Aの変異はマイクロサテライトの不安定性 (MSI) と免疫応答の変化と関連しています.
- ARID1Aのない肝細胞癌は血管新生が増加し,臓がんはEMTとYAP/ TAZ経由の転移におけるARID1Aの役割を示しています.
結論
- ARID1Aは,その変異がかなり異質である胃腸がんにおいて,ステージ特有の予後および治療的意義を示している.
- ARID1Aの二重の役割と,miRNAsによるその調節を理解することは,効果的な治療戦略の開発に不可欠です.
- ARID1A状態を精密腫瘍学に統合することで,ARID1A欠乏がんの診断,予後,治療の改善が期待できます.
関連する概念動画
Notch signaling was first discovered in Drosophila melanogaster, where it is involved in cell lineage differentiation. Notch signaling regulates the maintenance and differentiation of intestinal stem cells or ISCs by controlling the expression of atonal homolog 1 or Atoh1. Atoh1 directs cells to differentiate into secretory cells.
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
As the name suggests, non-LTR retrotransposons lack the long terminal repeats characteristic of the LTR retrotransposons. Additionally, both LTR and non-LTR retrotransposons use distinct mechanisms of mobilization. Non-LTR retrotransposons are further divided into two classes - Long interspersed nuclear elements (LINEs) and short interspersed nuclear elements (SINEs), both of which occur abundantly in most mammals, including humans. Some of the active non-LTR retrotransposons in humans are L1...
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
Erythropoietin-producing hepatocellular carcinoma receptor (Eph) and its ligand, Eph receptor-interacting protein (Ephrin) were first discovered in the human carcinoma cell line, hence the name. Ephrin-Eph interaction guides cells to reach their appropriate location in adult tissues. They also play an essential role in the immune system by helping in immune cell migration, adhesion, and activation. Based on their structure and function, Eph is divided into two classes — EphA and EphB.

